Zoek op
jentadueto-pil-2001.pdf
jentadueto-spc-1910.pdf
spc_atrovent_dosisaerosol
bijsluiter_combivent
Marloes Smittenaar
Camilla Krogh Lauritzen
Enterisol® Ileitis
For active immunisation of pigs from the age of three weeks against intestinal lesions caused by Lawsonia intracellularis infection and to reduce growth variability and weight loss associated with the disease.
Harro Ten Wolde
Prascend
Symptomatic treatment of clinical signs associated with pituitary pars intermedia dysfunction (PPID; also known as equine Cushing’s disease).
Nevenwerking
Nevenwerking
pagina niet gevonden
pagina niet gevonden
Producten voor diergezondheid
Producten voor diergezondheid
Veterinaire volksgezondheid
Veterinaire volksgezondheid
Vaccins
We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here.
Het onderzoeksproces
A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents.
Wereldwijde contractproductie biofarma
Biopharma Contract Manufacturing
Pluimvee
We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs.
Grass Roots-innovatie
Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators
Herkauwers
Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers.
Depressie
Depression
Patiëntgerichtheid
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Diergezondheid: onze verantwoordelijkheid
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
Chronische Nierziekte
Chronische Nierziekte
Boehringer Ingelheim
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.